BBNX

Beta Bionics, Inc.

Healthcare · Surgical & Medical Instruments & Apparatus

$19.41Sep 29, 2026

AI confidence 89% · prior close shown (market closed)

Investment Snapshot

Strong evidence · 3 sources

Why it matters

Beta Bionics, Inc. shows accelerating business momentum based on AlphaOS pipeline evidence, with mixed management execution.

Why it matters: Revenue +38% YoY in Q2 FY2026.

TrajectoryAccelerating
ExecutionMixed
CapitalRaising capital
RiskMedium

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +38% YoY in Q2 FY2026
  • Strong PBP Channel Growth

Pipeline evidence · 0d ago

BBNX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on BBNX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full BBNX earnings analysis

Reported figures for Beta Bionics, Inc. — research only, not investment advice.

Revenue YoY
+37.7%

Latest Intelligence

Updated

What happened recently for Beta Bionics, Inc. (BBNX) — events, not interpretation.

Event
Reported Q2 2026 revenue +38% YoY.
Also
Last session September 29, 2026 at $19.41.
Source
Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Beta Bionics, Inc. (BBNX)

Healthcare · Surgical & Medical Instruments & Apparatus

Investment Snapshot above is the primary AlphaOS analysis for Beta Bionics, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$873.25M
Revenue:
$32.01M

BBNX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Beta Bionics, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.